Matteo Levra-Giaj

La Tronche, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Lung cancer, comorbidities, and medication: the infernal trio.

Lung cancer, comorbidities, and medication: the infernal trio.

Journal: Frontiers in pharmacology

Published: August 11, 2022

Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey.

Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey.

Journal: JTO clinical and research reports

Published: June 16, 2022

Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab.

Machine Learning-Based Analysis of Treatment Sequences Typology in Advanced Non-Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab.

Journal: JCO clinical cancer informatics

Published: February 03, 2022

Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey.

Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 24, 2022

Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers.

Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 03, 2021

Implication of bronchopulmonary cancer patients in thoracic oncology

Implication of bronchopulmonary cancer patients in thoracic oncology

Journal: Revue des maladies respiratoires

Published: May 11, 2021

Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol.

Identification of a predictive metabolic signature of response to immune checkpoint inhibitors in non-small cell lung cancer: METABO-ICI clinical study protocol.

Journal: Respiratory medicine and research

Published: November 27, 2020

Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer.

Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer.

Journal: Cancers

Published: September 29, 2020

Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis.

Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis.

Journal: Translational lung cancer research

Published: August 31, 2020

Enteral nutrition in malnourished patients with lung cancer

Enteral nutrition in malnourished patients with lung cancer

Journal: Revue des maladies respiratoires

Published: January 27, 2020

Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter?

Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter?

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 04, 2019

Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis.

Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: A national data base analysis.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 24, 2019

Showing 1-12 of 30

Last Updated: 09/26/2026